Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Princeton, New Jersey
- Most recent report
- 8-K, filed Sep 2, 2026
- Incorporated
- Delaware
- Filings on record
- 386 filings
- On EDGAR
- CIK 1699382
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 24
News 8 of 45
Prospectuses and Registrations 8 of 18
- 424B5 Prospectus supplement for an offering Sep 2, 2026
- 424B3 Prospectus supplement for an offering Aug 31, 2026
- 424B5 Prospectus supplement for an offering Aug 31, 2026
- S-8 Registration statement for an employee plan Mar 6, 2026
- S-8 Registration statement for an employee plan Jan 28, 2025
- 424B3 Prospectus supplement for an offering Nov 27, 2024
- S-3 Shelf registration statement Nov 20, 2024
- S-8 Registration statement for an employee plan Jan 24, 2024
Proxies 8 of 12
- DEFA14A Extra proxy material Apr 22, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 22, 2026
- DEFA14A Extra proxy material Apr 25, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 25, 2025
- DEFA14A Extra proxy material Apr 24, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 24, 2024
- DEFA14A Extra proxy material Apr 28, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2023
Ownership 8 of 261
- SCHEDULE 13G/A Large holder reported a passive stake, amended Jul 28, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Jul 10, 2026
- 4 Insider reported a trade Jun 5, 2026
- 4 Insider reported a trade Jun 5, 2026
- 4 Insider reported a trade Jun 5, 2026
- 4 Insider reported a trade Jun 5, 2026
- 4 Insider reported a trade Jun 5, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended May 15, 2026
Other 8 of 26
- ARS Annual report sent to shareholders Apr 22, 2026
- ARS Annual report sent to shareholders Apr 25, 2025
- EFFECT Notice that a registration became effective Nov 27, 2024
- CORRESP Reply to SEC staff Nov 25, 2024
- UPLOAD Comment letter from SEC staff Nov 25, 2024
- SC TO-I/A Amended filing Aug 14, 2024
- SC TO-I Jul 16, 2024
- ARS Annual report sent to shareholders Apr 24, 2024
Everything here comes from PMV Pharmaceuticals, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.